# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-18-052765
Filing Date
2018-10-05
Accepted
2018-10-05 17:10:57
Documents
5
Period of Report
2018-12-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRELIMINARY PROXY STATEMENT | tv504256-pre14a.htm | PRE 14A | 131386
2 | GRAPHIC | lg_protalix.jpg | GRAPHIC | 25457
3 | GRAPHIC | sig_yossi-maimon.jpg | GRAPHIC | 9221
4 | GRAPHIC | tv504256_pc1.jpg | GRAPHIC | 399420
5 | GRAPHIC | tv504256_pc2.jpg | GRAPHIC | 541737
| Complete submission text file | 0001144204-18-052765.txt |  | 1476479

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 181111281
SIC: 2836 Biological Products, (No Diagnostic Substances)